Functional characterization of a unique mutant of ALK2, p.K400E, that is associated with a skeletal disorder, diffuse idiopathic skeletal hyperostosis.

[1]  Y. Mishina,et al.  Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing , 2020, Nature Communications.

[2]  H. Kato,et al.  Prevalence of Diffuse Idiopathic Skeletal Hyperostosis in the General Elderly Population , 2019, Clinical spine surgery.

[3]  Michael T. Zimmermann,et al.  Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification , 2019, American journal of medical genetics. Part A.

[4]  Y. Nakachi,et al.  Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily , 2018, International journal of molecular sciences.

[5]  A. Bullock,et al.  Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders. , 2018, Bone.

[6]  T. Katagiri,et al.  Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva. , 2017, Bone.

[7]  C. Keller,et al.  Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification , 2016, Science Translational Medicine.

[8]  T. Watabe,et al.  Bone Morphogenetic Proteins. , 2016, Cold Spring Harbor perspectives in biology.

[9]  Y. Matsumoto,et al.  Neofunction of ACVR1 in fibrodysplasia ossificans progressiva , 2015, Proceedings of the National Academy of Sciences.

[10]  Lily Huang,et al.  ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A , 2015, Science Translational Medicine.

[11]  S. Ohte,et al.  Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors. , 2015, Molecular endocrinology.

[12]  F. Nascimento,et al.  Diffuse idiopathic skeletal hyperostosis: A review , 2014, Surgical neurology international.

[13]  T. Katagiri,et al.  The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway , 2013, Biological chemistry.

[14]  F. Kaplan,et al.  Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis , 2012, Disease Models & Mechanisms.

[15]  Jie Feng,et al.  Association of a BMP9 Haplotype with Ossification of the Posterior Longitudinal Ligament (OPLL) in a Chinese Population , 2012, PloS one.

[16]  T. Zimmers,et al.  BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. , 2012, Blood.

[17]  Jie Feng,et al.  A new haplotype in BMP4 implicated in ossification of the posterior longitudinal ligament (OPLL) in a Chinese population , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[18]  Y. Okazaki,et al.  A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. , 2011, Biochemical and biophysical research communications.

[19]  Y. Hai,et al.  T allele at site 6007 of bone morphogenetic protein-4 gene increases genetic susceptibility to ossification of the posterior longitudinal ligament in male Chinese Han population. , 2010, Chinese medical journal.

[20]  Y. Okazaki,et al.  Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. , 2009, The Journal of biological chemistry.

[21]  J. Inman,et al.  Bmc Cell Biology a Rapid and Sensitive Bioassay for the Simultaneous Measurement of Multiple Bone Morphogenetic Proteins. Identification and Quantification of Bmp4, Bmp6 and Bmp9 in Bovine and Human Serum , 2022 .

[22]  L. David,et al.  Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.

[23]  T. Luedde,et al.  Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells , 2007, Digestive Diseases and Sciences.

[24]  R. Kamijo,et al.  Purification and identification of a BMP-like factor from bovine serum. , 2006, Biochemical and biophysical research communications.

[25]  In Ho Choi,et al.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva , 2006, Nature Genetics.

[26]  N. Takahashi,et al.  Identification of a BMP‐responsive element in Id1, the gene for inhibition of myogenesis , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[27]  T. Nakajima,et al.  Large‐Scale Screening for Candidate Genes of Ossification of the Posterior Longitudinal Ligament of the Spine , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[29]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Oppermann,et al.  Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.

[31]  E. Drier,et al.  OP‐1 cDNA encodes an osteogenic protein in the TGF‐beta family. , 1990, The EMBO journal.

[32]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[33]  M. Urist,et al.  Bone Morphogenetic Protein , 1971, Journal of dental research.

[34]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.